DAVID B. KAYSEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Panbela Therapeutics, Inc.

Filing Date Source Excerpt
2016-04-11 David B. Kaysen has served as our President and Chief Executive Officer and as a director of our Company since the effective time of the Merger.
2017-04-27 David B. Kaysen has served as our President and Chief Executive Officer and as a director of our Company since September 4, 2015... Executive Compensation: David B. Kaysen - $1,265,595 total compensation in 2016.
2017-08-22 Executive Officers and Directors David B. Kaysen 592,750 Includes 517,750 shares subject to stock options and 25,000 shares subject to warrants.
2018-04-16 David B. Kaysen has served as our President and Chief Executive Officer and as a director of our Company since September 4, 2015... David B. Kaysen received $302,500 in 2017.

Data sourced from SEC filings. Last updated: 2026-03-05